Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XLO | US
0.03
3.88%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.81
0.79
0.83
0.77
Xilio Therapeutics Inc. a clinical-stage biotechnology company discovers and develops tumor-activated immuno-oncology therapies. Its checkpoint inhibitor program includes XTX101 an investigational Fc-enhanced tumor-activated anti-CTLA-4 mAb that is in Phase 1 clinical trial for patients with advanced solid tumors. The company also develops cytokine programs which comprises XTX202 a tumor-activated IL-2; and XTX301 an investigational tumor-activated engineered IL-12 molecule. Xilio Therapeutics Inc. was founded in 2016 and is headquartered in Waltham Massachusetts.
View LessStrength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
51.8%1 month
48.5%3 months
68.1%6 months
73.8%-
-
1.02
0.26
0.10
-0.11
-
-
-64.91M
35.57M
35.57M
-
-622.57
-
-
-130.03
0.68
0.38
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.12
Range1M
0.13
Range3M
0.35
Rel. volume
1.27
Price X volume
97.65K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| FibroGen Inc | FGEN | Biotechnology | 0.3745 | 37.60M | -4.34% | n/a | -70.49% |
| NextCure Inc | NXTC | Biotechnology | 1.34 | 37.49M | -2.19% | n/a | 7.21% |
| PASSAGE BIO INC. | PASG | Biotechnology | 0.5885 | 36.35M | 1.55% | n/a | 28.88% |
| Lantern Pharma Inc. | LTRN | Biotechnology | 3.36 | 36.17M | -2.33% | n/a | 0.71% |
| VYNE Therapeutics Inc | VYNE | Biotechnology | 2.4 | 35.40M | 8.35% | 1.29 | 0.19% |
| QNCX | QNCX | Biotechnology | 0.8165 | 35.34M | 2.70% | n/a | 30.62% |
| OCUP | OCUP | Biotechnology | 1.33 | 34.84M | 0.76% | n/a | 0.00% |
| IN8bio Inc. Common Stock | INAB | Biotechnology | 0.475 | 34.46M | 75.28% | n/a | 43.30% |
| vTv Therapeutics Inc | VTVT | Biotechnology | 14 | 34.06M | -0.99% | n/a | 1.55% |
| OKYO Pharma Limited | OKYO | Biotechnology | 0.98 | 33.16M | -3.92% | n/a | -107.88% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 13.44 | 20.47M | 4.19% | n/a | 204.46% |
| ILAG | ILAG | Building Products & Equipment | 1 | 18.06M | -2.91% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
| Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.11 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.02 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 68.13 | - | Par |
| Debt to Equity | 0.26 | -1.23 | Expensive |
| Debt to Assets | 0.10 | 0.25 | Cheaper |
| Market Cap | 35.57M | - | Emerging |